Highlights Sandoz Group AG

Equities

Real-time Estimate Cboe Europe Other stock markets 03:34:35 2024-06-07 am EDT			5-day change	1st Jan Change
31.47 ^CHF	-0.57%		-1.87%	+16.26%

May. 22	Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	CF
May. 22	Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	MT

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	May. 08	MT
Swiss Market Index Closes Higher; Sandoz Gains	May. 08	MT
SANDOZ : Sandoz’s improvements are worth betting on	May. 08
SANDOZ : Q1 miss not a worry; expect another boost for the share price	May. 07
Sandoz: 5% sales growth in Q1	May. 07	CF
Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook	May. 07	MT
Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	Apr. 30
Sandoz Group AG Approves Dividend, Payable on May 7, 2024	Apr. 30	CI
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation	Apr. 30	DJ
Sandoz Group Settles Patent Disputes with Amgen	Apr. 30	MT
Sandoz reaches agreement with Amgen over patent dispute	Apr. 30	RE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	Apr. 25	RE
Sandoz Confirms European Commission Approval of Pyzchiva® (ustekinumab), Further Strengthening Immunology Offering	Apr. 22	CI
Bausch wins US appeal to block Alvogen generic of diarrhea drug	Apr. 11	RE
Sandoz: new production site in Kundl	Mar. 21	CF
Sandoz Launches New Antibiotic Production Plant in Kundl, Austria	Mar. 21	MT
Sandoz Group Opens New Antibiotic Production Facility in Kundl, Austria	Mar. 21	MT

No results for this search

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 08:08 am EDT